Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GHSR | Q92847 | 5/20 | 0.65 |
| ▸ | KISS1R | Q969F8 | 7/20 | 0.65 |
| ▸ | NPY1R | P25929 | 3/20 | 0.61 |
| ▸ | NPY2R | P49146 | 3/20 | 0.61 |
| ▸ | NPY4R | P50391 | 3/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31404052 | 0.96 | GHSR (0.68) | GHSRKISS1RNPY1RNPY2RNPY4R | |
| SCHEMBL29550957 | 0.93 | KISS1R (0.64) | GHSRKISS1RNPY1RNPY2RNPY4R | |
| SCHEMBL29550946 | 0.93 | KISS1R (0.64) | GHSRKISS1RNPY1RNPY2RNPY4R | |
| SCHEMBL29550650 | 0.91 | GHSR (0.63) | GHSRKISS1RNPY1RNPY2RNPY4R | |
| SCHEMBL12912367 | 0.91 | KISS1R (0.62) | GHSRKISS1RNPY1RNPY2RNPY4R | |
| SCHEMBL29706289 | 0.91 | KISS1R (0.62) | GHSRKISS1RNPY1RNPY2RNPY4R | |
| SCHEMBL3486221 | 0.91 | GHSR (0.61) | GHSRKISS1RNPY1RNPY2RNPY4R | |
| SCHEMBL29434320 | 0.91 | GHSR (0.61) | GHSRKISS1RNPY1RNPY2RNPY4R | |
| SCHEMBL3486226 | 0.91 | GHSR (0.61) | GHSRKISS1RNPY1RNPY2RNPY4R | |
| SCHEMBL30466124 | 0.91 | GHSR (0.61) | GHSRKISS1RNPY1RNPY2RNPY4R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070111930-A1 | PROCESS FOR PREPARING VAPREOTIDE | DR. REDDY'S LABORATORIES, INC. | 2007-05-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070111930-A1 | PROCESS FOR PREPARING VAPREOTIDE | VIP, SSTR4, SSTR5 | GHSR 16/4885KISS1R 360/4885NPY1R 47/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.